A ‘Critical Pathogen’: The Rise of Drug-Resistant Fungal Diseases
As the planet warms, fungi are adapting to survive at higher temperatures, becoming drug-resistant—and posing threats to human health.
How and why diseases and injuries occur in different populations, and informing prevention and control measures
Explore the latest public health research and insights about epidemiology.
As the planet warms, fungi are adapting to survive at higher temperatures, becoming drug-resistant—and posing threats to human health.
Looking for prominent experts in the field of epidemiology? They're here at the Bloomberg School of Public Health.
David Celentano, ScD ’77, MHS ’75, is an infectious disease epidemiologist who researches behavioral risk factors for HIV/AIDS, STIs, and other infections.
Elizabeth A. Platz, ScD, MPH, uses molecular epidemiology to understand the mechanisms of cancer incidence and progression to identify prevention and treatment strategies.
Keri N Althoff, PhD '08, MPH '05, uses large-scale longitudinal data to answer otherwise unanswerable questions and improve health, particularly for populations underrepresented in research.
David Dowdy, MD, PhD ’08, ScM ’02, studies the implementation of interventions to fight tuberculosis, the world's most deadly infectious disease.